Is Zhongchao Inc. (ZCMD) a Buy, Sell, or Hold?
Zhongchao Inc.
NASDAQ:ZCMD
$1.65 USD
-$0.07 (-4.07%)
- Volume
- 183.17K
- Average Volume
- 1.83M
- Market Capitalization
- $57.3K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $967.20
- Year Low
- $0.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.11
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Weiguang Yang |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Current Symbol | ZCMD |
| CUSIP | G9897X149 |
| CIK | 0001785566 |
| Web | http://www.izcmd.com |
| Phone | 86 21 3220 5987 |
| Currency | USD |
| Employees | 33 |
| Country | CN |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 11.11 |
| Quick Ratio | 11.11 |
| Cash Ratio | 5.30 |
Sales & Book Value
| Annual Sales | $11.37M |
| Price / Sales | 0.01 |
| Cash Flow | 18.59 |
| Price / Cash Flow | 0.08 |
| Price / Book | 0.00 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-172.05 |
| Trailing P/E Ratio | -0.01 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-6.31M |
| Net Margin | -55.47% |
| Pretax Margin | -50.71% |
| Return on Equity | -32.44% |
| Return on Assets | -25.95% |
Financials Score
| AltmanZ Score | 0.31 |
| Piotroski Score | 4.00 |
| Working Capital | 15.44M |
| Total Assets | 24.32M |
| Ebit | -5.71M |
| Market Cap | 58.87K |
| Total Liabilities | 1.72M |
Poll Results
About Zhongchao Inc. (NASDAQ:ZCMD) Stock
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare conte ... nt. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Zhongchao Inc. Announces 1-for-3 Share Consolidation
2026-06-25 08:00:00
SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-3 share consolidation of the Company's ordinary shares of US$0.248 par value each (the "Share Consolidation"). Beginning with the opening of trading on June 29, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD," but under a new CUSIP number of G9897X149.
Zhongchao Inc. Announces 1-for-31 Share Consolidation
2026-06-04 08:00:00
SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-31 share consolidation of the Company's ordinary shares of US$0.008 par value each (the "Share Consolidation"). Beginning with the opening of trading on June 8, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD," but under a new CUSIP number of G9897X131.
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
2026-05-29 11:00:00
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering PR Newswire SHANGHAI, May 29, 2026
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
2026-05-29 10:00:00
SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a best efforts public offering with gross proceeds to the Company expected to be approximately $5 million, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any warrant offered. The offering is comprised of 9,259,260 units (each a "Unit"), each consisting of one Class A ordinary share of the Company, par value $0.008 per share (the "Class A ordinary shares"), or in lieu thereof, a pre-funded warrant, and one warrant to purchase one Class A ordinary share (each, a "Warrant").
Reviewing Standard BioTools (NASDAQ:LAB) & Zhongchao (NASDAQ:ZCMD)
2026-04-27 02:38:50
Standard BioTools (NASDAQ: LAB - Get Free Report) and Zhongchao (NASDAQ: ZCMD - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Insider and Institutional Ownership 53.7% of Standard BioTools
Frequently Asked Questions
-
What is the current Zhongchao Inc. (ZCMD) stock price?
-
Zhongchao Inc.(NASDAQ:ZCMD) stock price is $1.65 in the last trading session. During the trading session, ZCMD stock reached the peak price of $967.2 while $0.803 was the lowest point it dropped to. The percentage change in ZCMD stock occurred in the recent session was --4.07% while the dollar amount for the price change in ZCMD stock was -$-0.07.
-
ZCMD's industry and sector of operation?
-
The NASDAQ listed ZCMD is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of ZCMD?
-
Weiguang Yang | Founder, Chairman, President & Chief Executive Officer
Pei Xu | Chief Financial Officer, Secretary & Director
|
|
| -
How many employees does ZCMD have?
-
Number of ZCMD employees currently stands at 33. ZCMD operates from 841 Yan’an Middle Road, Shanghai, SH 200040, CN.
-
Link for ZCMD official website?
-
Official Website of ZCMD is: http://www.izcmd.com
-
How do I contact ZCMD?
-
ZCMD could be contacted at phone #86 21 3220 5987 and can also be accessed through its website. ZCMD operates from 841 Yan’an Middle Road, Shanghai, SH 200040, CN.
-
How many shares of ZCMD are traded daily?
-
The average number of ZCMD shares traded daily for last 3 months was 1.83M.
-
What is the market cap of ZCMD currently?
-
The market value of ZCMD currently stands at $57.3K with its latest stock price at $1.65